Millennium Management LLC Buys 17,899 Shares of Azenta, Inc. (NASDAQ:AZTA)

Millennium Management LLC grew its position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 19.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 108,175 shares of the company's stock after acquiring an additional 17,899 shares during the quarter. Millennium Management LLC owned about 0.24% of Azenta worth $5,409,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of the company. SG Americas Securities LLC bought a new position in shares of Azenta in the fourth quarter valued at approximately $813,000. KBC Group NV boosted its holdings in Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after acquiring an additional 698 shares during the last quarter. Conestoga Capital Advisors LLC raised its holdings in shares of Azenta by 65.0% in the fourth quarter. Conestoga Capital Advisors LLC now owns 1,577,881 shares of the company's stock valued at $78,894,000 after purchasing an additional 621,830 shares during the last quarter. State of Alaska Department of Revenue lifted its position in shares of Azenta by 355.2% during the fourth quarter. State of Alaska Department of Revenue now owns 25,899 shares of the company's stock valued at $1,294,000 after purchasing an additional 20,210 shares in the last quarter. Finally, Empowered Funds LLC bought a new position in shares of Azenta during the fourth quarter valued at about $293,000. 99.08% of the stock is owned by institutional investors and hedge funds.

Azenta Stock Performance

AZTA traded down $0.61 on Friday, reaching $26.72. The company had a trading volume of 715,882 shares, compared to its average volume of 695,794. Azenta, Inc. has a 52-week low of $23.91 and a 52-week high of $63.58. The company has a market cap of $1.22 billion, a price-to-earnings ratio of -8.97 and a beta of 1.64. The business has a 50 day simple moving average of $28.02 and a 200 day simple moving average of $40.37.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. Azenta's quarterly revenue was up 5.1% compared to the same quarter last year. During the same period in the previous year, the business posted $0.06 earnings per share. As a group, equities research analysts predict that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on AZTA shares. Evercore ISI upped their price objective on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a research note on Thursday, February 6th. Needham & Company LLC reduced their price target on shares of Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a research report on Wednesday, May 7th. Finally, TD Cowen raised shares of Azenta to a "hold" rating in a research report on Thursday, February 27th.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.